Table 13.
Risk evaluation of mycotoxins in infant formulas.
| Mycotoxin | Origin | TDI% | TDI (ng/kg b.w/day) | Reference | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–1 Month |
1–2 Months |
2–3 Months |
3–4 Months |
4–5 Months |
5–6 Months |
6–7 Months |
7–8 Months |
8–9 Months |
||||
| NIV | Asia | 1200 | ||||||||||
| South Korea |
6 | 6 | 6 | 5 | 6 | 5 | 4 | 4 | 3 | [28] | ||
| OTA | Africa | 14 | ||||||||||
| Burkina Faso |
15 | 16 | 16 | 14 | 15 | 14 | 11 | 11 | 8 | [21] | ||
| America | ||||||||||||
| Canada | 22 | 23 | 23 | 21 | 22 | 21 | 16 | 15 | 11 | [21] | ||
| Europe | ||||||||||||
| Italy | 13 | 14 | 14 | 13 | 14 | 13 | 10 | 9 | 7 | [21] | ||
| Turkey | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | |||
| ZEN | Europe | 250 | ||||||||||
| Italy | 0.22 | 0.23 | 0.23 | 0.21 | 0.23 | 0.21 | 0.16 | 0.15 | 0.11 | [31] | ||